Liu S, Li L, Liang Y, Tan Y, Wang X, Feng Y
Brief Bioinform. 2025; 26(1).
PMID: 39883516
PMC: 11781221.
DOI: 10.1093/bib/bbaf032.
Chen K, Yang H, Xu G, Hu Y, Tian X, Qin S
RSC Med Chem. 2025; .
PMID: 39760102
PMC: 11694649.
DOI: 10.1039/d4md00781f.
Yan Y, Deng W, Shi C, Xie J, Sui D
Front Med (Lausanne). 2024; 11:1500670.
PMID: 39712183
PMC: 11659017.
DOI: 10.3389/fmed.2024.1500670.
Shen F, Song Y, Qiang Y, Gao X, Li S, Zhang R
Psoriasis (Auckl). 2024; 14:103-114.
PMID: 39347516
PMC: 11430410.
DOI: 10.2147/PTT.S484609.
Chen L, Chen H, Mo L, He M, Zhao Y, Tan T
J Glob Health. 2024; 14:04139.
PMID: 39105325
PMC: 11301618.
DOI: 10.7189/jogh.14.04139.
New-Onset Hidradenitis Suppurativa in Psoriasis Patients: A Multi-Center, Retrospective Cohort Study.
Li C, Lo S, Tsai R, Chang H, Gau S
Life (Basel). 2024; 14(6).
PMID: 38929713
PMC: 11205059.
DOI: 10.3390/life14060730.
Granzyme K mediates IL-23-dependent inflammation and keratinocyte proliferation in psoriasis.
Richardson K, Aubert A, Turner C, Nabai L, Hiroyasu S, Pawluk M
Front Immunol. 2024; 15:1398120.
PMID: 38903528
PMC: 11188347.
DOI: 10.3389/fimmu.2024.1398120.
Comorbidities among adult patients with psoriasis in Tianjin: a cross-sectional analysis of the Health Database study.
Zhang Y, Guo Y, Zhang K, Fan L, Ma J, Li Y
BMJ Open. 2024; 14(5):e083683.
PMID: 38772892
PMC: 11110554.
DOI: 10.1136/bmjopen-2023-083683.
Deep Learning-Based Psoriasis Assessment: Harnessing Clinical Trial Imaging for Accurate Psoriasis Area Severity Index Prediction.
Xing Y, Zhong S, Aronson S, Rausa F, Webster D, Crouthamel M
Digit Biomark. 2024; 8(1):13-21.
PMID: 38440046
PMC: 10911790.
DOI: 10.1159/000536499.
Burden of psoriasis in young adults worldwide from the global burden of disease study 2019.
Zhang Y, Dong S, Ma Y, Mou Y
Front Endocrinol (Lausanne). 2024; 15:1308822.
PMID: 38414821
PMC: 10897041.
DOI: 10.3389/fendo.2024.1308822.
Exploring the Effectiveness of Biological Therapy in Patients with Psoriasis: Body Image and Quality of Life.
Wu C, Chang Y, Yao W, Chiang T
Medicina (Kaunas). 2024; 60(1).
PMID: 38256420
PMC: 10819774.
DOI: 10.3390/medicina60010160.
Unraveling Transcriptome Profile, Epigenetic Dynamics, and Morphological Changes in Psoriasis-like Keratinocytes: "Insights into Similarity with Psoriatic Lesional Epidermis".
Ghaffarinia A, Poliska S, Ayaydin F, Goblos A, Parvaneh S, Manczinger M
Cells. 2023; 12(24).
PMID: 38132145
PMC: 10741855.
DOI: 10.3390/cells12242825.
Herring roe oil in treatment of psoriasis - influence on immune cells and cytokine network.
Petrovic A, Bueide I, Tveit K, Hallaraker H, Bjorndal B, Holmes T
Front Immunol. 2023; 14:1128986.
PMID: 37744329
PMC: 10515196.
DOI: 10.3389/fimmu.2023.1128986.
A panel of blood-based circulatory miRNAs with diagnostic potential in patients with psoriasis.
Madaan P, Sharma U, Tyagi N, Brar B, Bansal S, Kushwaha H
Front Med (Lausanne). 2023; 10:1207993.
PMID: 37700769
PMC: 10493330.
DOI: 10.3389/fmed.2023.1207993.
Xiaoyin Jiedu Granules may alleviate psoriasis-like skin diseases in mice by regulating sphingosine 1-phosphate receptor expression and reducing Th17 cells.
Wang Z, Zhang G, Zhang H, Li L
Heliyon. 2023; 9(8):e19109.
PMID: 37636348
PMC: 10448460.
DOI: 10.1016/j.heliyon.2023.e19109.
Extracts from Wolff attenuate imiquimod-induced psoriasis-like inflammation by inhibiting Th17 cells.
Wang M, Yin X, Zeng Y, Hu C, Xue Y, Fang Q
Heliyon. 2023; 9(7):e17315.
PMID: 37539258
PMC: 10394919.
DOI: 10.1016/j.heliyon.2023.e17315.
Evidence of the content validity, acceptability, and feasibility of a new Patient-Reported Impact of Dermatological Diseases measure.
Pattinson R, Trialonis-Suthakharan N, Hewitt R, Lopez M, Tahmasebi Gandomkari N, Austin J
Front Med (Lausanne). 2023; 10:1020523.
PMID: 37215711
PMC: 10196461.
DOI: 10.3389/fmed.2023.1020523.
Comparative Analysis of the Therapeutic Effects of Fresh and Cryopreserved Human Umbilical Cord Derived Mesenchymal Stem Cells in the Treatment of Psoriasis.
Wang Z, Hu Y, Wang X, Chen Y, Wu D, Ji H
Stem Cell Rev Rep. 2023; 19(6):1922-1936.
PMID: 37199874
DOI: 10.1007/s12015-023-10556-8.
Izokibep: Preclinical development and first-in-human study of a novel IL-17A neutralizing Affibody molecule in patients with plaque psoriasis.
Klint S, Feldwisch J, Gudmundsdotter L, Dillner Bergstedt K, Gunneriusson E, Hoiden Guthenberg I
MAbs. 2023; 15(1):2209920.
PMID: 37184136
PMC: 10187109.
DOI: 10.1080/19420862.2023.2209920.
Riluzole-Loaded Nanostructured Lipid Carriers for Hyperproliferative Skin Diseases.
Llorente X, Esteruelas G, Bonilla L, Agudelo M, Filgaira I, Lopez-Ramajo D
Int J Mol Sci. 2023; 24(9).
PMID: 37175765
PMC: 10179084.
DOI: 10.3390/ijms24098053.